134 related articles for article (PubMed ID: 35339340)
1. Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
Pring ET; Malietzis G; Gould LE; Lung P; Drami I; Athanasiou T; Jenkins JT
Eur J Surg Oncol; 2022 Jul; 48(7):1664-1670. PubMed ID: 35339340
[TBL] [Abstract][Full Text] [Related]
2. Myosteatotic and sarcopenic obesity impact postoperative outcomes more robustly than visceral obesity in general surgery patients, with differences by sex.
Jones A; Silver HJ
Clin Nutr; 2023 May; 42(5):625-635. PubMed ID: 36947987
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
[TBL] [Abstract][Full Text] [Related]
5. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
6. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
7. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer.
Pedrazzani C; Conti C; Zamboni GA; Chincarini M; Turri G; Valdegamberi A; Guglielmi A
Clin Nutr; 2020 Dec; 39(12):3763-3770. PubMed ID: 32336524
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
9. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
10. Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
Hopkins JJ; Skubleny D; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Ann Surg Oncol; 2018 May; 25(5):1381-1394. PubMed ID: 29488190
[TBL] [Abstract][Full Text] [Related]
11. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
12. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
13. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
14. Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.
Zhang Y; Wang JP; Wang XL; Tian H; Gao TT; Tang LM; Tian F; Wang JW; Zheng HJ; Zhang L; Gao XJ; Li GL; Wang XY
Curr Oncol; 2018 Oct; 25(5):e411-e422. PubMed ID: 30464692
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.
Lurje I; Czigany Z; Eischet S; Bednarsch J; Ulmer TF; Isfort P; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
Hepatol Commun; 2022 Sep; 6(9):2400-2417. PubMed ID: 35616275
[TBL] [Abstract][Full Text] [Related]
16. Computed-Tomography Body Composition Analysis Complements Pre-Operative Nutrition Screening in Colorectal Cancer Patients on an Enhanced Recovery after Surgery Pathway.
Klassen P; Baracos V; Gramlich L; Nelson G; Mazurak V; Martin L
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291416
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle and visceral adipose radiodensities are pre-surgical, non-invasive markers of aggressive kidney cancer.
Furberg H; Bradshaw PT; Knezevic A; Olsson L; Petruzella S; Stein E; Paris M; Scott J; Akin O; Hakimi AA; Russo P; Sanchez A; Caan B; Mourtzakis M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):726-734. PubMed ID: 38263932
[TBL] [Abstract][Full Text] [Related]
18. Influence of body composition profile on outcomes following colorectal cancer surgery.
Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenic obesity and its relation with muscle quality and mortality in patients on chronic hemodialysis.
Sabatino A; Avesani CM; Regolisti G; Adinolfi M; Benigno G; Delsante M; Fiaccadori E; Gandolfini I
Clin Nutr; 2023 Aug; 42(8):1359-1368. PubMed ID: 37418843
[TBL] [Abstract][Full Text] [Related]
20. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
